Chemomab Therapeutics (CMMB) Tax Rate (2022 - 2023)

Chemomab Therapeutics (CMMB) posted Tax Rate of 1.33% for Q3 2023, down 410.39% on a QoQ basis from 0.43% in Q2 2023.

Chemomab Therapeutics (CMMB) Tax Rate (2022 - 2023) Analysis & Trends

Chemomab Therapeutics' Tax Rate history runs 2 years deep, the most recent figure standing at 1.33% for Q3 2023.

Quarterly Tax Rate changed N/A year-over-year to 1.33% in Q3 2023, while the trailing twelve-month figure through Sep 2023 was 0.03% (up 1167.0% YoY) and the FY2022 annual result came in at 1.89%, changed N/A from the prior year.
Tax Rate was 1.33% for Q3 2023 at Chemomab Therapeutics, down from 0.43% in the prior quarter.
Across five years, Tax Rate topped out at 0.43% in Q2 2023 and bottomed at 8.08% in Q2 2022.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Oculis Holding AG	67,072.09 Bn	67,072.09 Bn	-	-0.34
2	Nanobiotix	1,894.61 Bn	1,894.55 Bn	-	-
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	5.61
4	BeOne Medicines	471.64 Bn	466.85 Bn	1.35 Bn	12.29
5	Vertex Pharmaceuticals	121.72 Bn	114.47 Bn	2.59 Bn	17.68
6	Regeneron Pharmaceuticals	68.28 Bn	59.52 Bn	3.31 Bn	12.51
7	Belite Bio	61.40 Bn	61.40 Bn	-	-
8	Argenx Se	56.94 Bn	56.94 Bn	1.18 Bn	-13.70
9	Revolution Medicines	37.37 Bn	37.37 Bn	-	-
10	Chemomab Therapeutics	704.11 Mn	693.75 Mn	-	-

Historic Data

Download Data

Date	Value
Sep 30, 2023	-1.33
Sep 30, 2023	-1.33
Sep 30, 2023	-1.33
Jun 30, 2023	0.43
Jun 30, 2023	0.43
Jun 30, 2023	0.43
Mar 31, 2023	0.24
Mar 31, 2023	0.24
Mar 31, 2023	0.24
Dec 31, 2022	0.12
Dec 31, 2022	0.12
Dec 31, 2022	0.12
Jun 30, 2022	-8.08
Jun 30, 2022	-8.08
Jun 30, 2022	-8.08